Your browser doesn't support javascript.
loading
Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization.
Jagodinsky, Justin C; Bates, Amber M; Clark, Paul A; Sriramaneni, Raghava N; Havighurst, Thomas C; Chakravarty, Ishan; Nystuen, Erin J; Kim, KyungMann; Sondel, Paul M; Jin, Won Jong; Morris, Zachary S.
Afiliação
  • Jagodinsky JC; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Bates AM; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Clark PA; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Sriramaneni RN; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Havighurst TC; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Chakravarty I; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Nystuen EJ; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Kim K; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Sondel PM; Department of Pediatrics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Jin WJ; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA zmorris@humonc.wisc.edu wjin37@wisc.edu.
  • Morris ZS; Department of Human Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA zmorris@humonc.wisc.edu wjin37@wisc.edu.
J Immunother Cancer ; 10(10)2022 Oct.
Article em En | MEDLINE | ID: mdl-36192087

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Receptor 4 Toll-Like Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Receptor 4 Toll-Like Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos